通过脂酶处理的Hericenone C的脱化衍生物与其母化合物相比,显示出增强的神经保护性质
Sonam Tamrakar1,2, Dongmei Wang1, Eri Hiraki1
1Department of Agro-Environmental Sciences, Faculty of Agriculture, Kyushu University, Fukuoka 819-0395, Japan.
Molecules (Basel, Switzerland)
|June 10, 2023
概括
来自Hericium erinaceus的Hericenone C可能比其脱糖形式更不有效. 甲基显示出更强的神经保护性质和更高的大脑衍生神经营养因子 (BDNF) mRNA表达,这表明它是更生物活性的化合物.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 自然产品 化学 化学
背景情况:
- 黑 (Hericium erinaceus) 或亚马布希塔克 (Yamabushitake) 含有类似于赫里森C的化合物,可以刺激神经营养因子.
- 由于脂酶活性,Hericenone C的脂肪酸链在生理条件下可能不稳定.
研究的目的:
- 为了研究海里森C的代谢命运.
- 为了比较Hericenone C及其潜在代谢物, deacylhericenone 的神经保护作用.
主要方法:
- 酶酶对赫里森C进行治疗.
- 使用LC-QTOF-MS和1H-NMR,对产生的化合物进行隔离和结构识别.
- 评估神经保护性质和BDNF mRNA表达在人类星细胞瘤细胞.
主要成果:
- 脂酶处理产生了脱烯,一种缺乏脂肪酸侧链的衍生物.
- 与Hericenone C相比,Deacylhericenone显示BDNF mRNA表达显著更高.
- 脱烯提供了对过氧化诱导的氧化应激的优越保护.
结论:
- 脱烯是赫里森C的主要生物活性形式.
- 脱糖形式表现出增强的神经保护性和神经营养因子刺激活性.
相关概念视频
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Benzene to 1,4-Cyclohexadiene: Birch Reduction Mechanism
Birch reduction uses solvated electrons as reducing agents. The reaction converts benzene to 1,4-cyclohexadiene. The reaction proceeds by the transfer of a single electron to the ring to form a benzene radical anion. This anion is highly basic—it abstracts a proton from the alcohol to form a cyclohexadienyl radical. Another single electron transfer gives the cyclohexadienyl anion. A proton transfer from the alcohol forms 1,4-cyclohexadiene. Since this reduction occurs via radical anion...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Phase I Reactions: Reductive Reactions
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...


